Patents by Inventor Susan M. Dallabrida

Susan M. Dallabrida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS, SYSTEM, AND KIT FOR MONITORING, DIAGNOSING, AND TREATING IMPULSIVE AGGRESSION
    Publication number: 20220016128
    Abstract: The present disclosure relates to the treatment of impulsive aggression with molindone as an add-on therapy where patients are already receiving treatment for the underlying disease or disorder, e.g. attention deficit hyperactivity disorder (ADHD), bipolar disorder, autism, Tourette's syndrome or post traumatic stress disorder (PTSD), using evidence-based impulsive aggression testing methodologies and systems.
    Type: Application
    Filed: September 29, 2021
    Publication date: January 20, 2022
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Jennifer DUGAN STOCKS, Christopher EVANS, Seung HWANG, Susan M. DALLABRIDA
  • METHODS, SYSTEM, AND KIT FOR MONITORING, DIAGNOSING, AND TREATING IMPULSIVE AGGRESSION
    Publication number: 20200246348
    Abstract: The present disclosure relates to the treatment of impulsive aggression with molindone as an add-on therapy where patients are already receiving treatment for the underlying disease or disorder, e.g. attention deficit hyperactivity disorder (ADHD), bipolar disorder, autism, Tourette's syndrome or post traumatic stress disorder (PTSD), using evidence-based impulsive aggression testing methodologies and systems.
    Type: Application
    Filed: April 17, 2020
    Publication date: August 6, 2020
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Jennifer DUGAN STOCKS, Christopher Evans, Seung Hwang, Susan M. Dallabrida
  • METHODS, SYSTEM, AND KIT FOR MONITORING, DIAGNOSING, AND TREATING IMPULSIVE AGGRESSION
    Publication number: 20170312289
    Abstract: The present disclosure relates to the treatment of impulsive aggression with molindone as an add-on therapy where patients are already receiving treatment for the underlying disease or disorder, e.g. attention deficit hyperactivity disorder (ADHD), bipolar disorder, autism, Tourette's syndrome or post traumatic stress disorder (PTSD), using evidence-based impulsive aggression testing methodologies and systems.
    Type: Application
    Filed: April 27, 2017
    Publication date: November 2, 2017
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Jennifer DUGAN STOCKS, Christopher EVANS, Seung HWANG, Susan M. DALLABRIDA
  • CELL-PROTECTIVE PEPTIDES AND USES THEREOF
    Publication number: 20130303457
    Abstract: A peptide comprising the amino acid sequence, X1X2RX3DX4X5X6X7 is provided, as well as a biomaterial comprising the peptide for use to treat conditions resulting from cell death or apoptosis.
    Type: Application
    Filed: August 26, 2011
    Publication date: November 14, 2013
    Applicant: University of Toronto
    Inventors: Milica Radisic, Susan M. Dallabrida, Maria Ann Rupnick